Blog & Insights
Intelligence for people who import medicines
No press releases, no filler. Practical writing on registration, tenders, logistics and distribution economics — from a team that does this work daily.
On the editorial calendar
One hundred topics our team is writing, in the order our readers ask for them. Want one prioritized? Tell us.
Import Guides
- How to Import Pharmaceuticals from India: A Step-by-Step Guide for Distributors
- Choosing a Pharmaceutical Export Partner: 12 Questions That Reveal Everything
- CIF vs FOB vs EXW: Which Incoterm Should Pharmaceutical Importers Choose?
- How to Verify an Indian Pharmaceutical Manufacturer Before Your First Order
- Letters of Credit in Pharmaceutical Trade: A Practical Guide for Importers
- Pharmaceutical Import Licenses Explained: Requirements by Region
- How to Calculate the True Landed Cost of Imported Medicines
- First Pharmaceutical Import? The 10 Mistakes New Distributors Make
- How to Read a Certificate of Analysis: A Buyer's Guide
- Pre-Shipment Inspection for Medicines: SGS, Intertek and When You Need Them
- Minimum Order Quantities in Pharma Export: What's Negotiable and What Isn't
- How Pharmaceutical Payment Terms Evolve from Advance to Open Credit
- Importing Veterinary Medicines: How the Process Differs from Human Pharma
- Parallel Imports vs Authorized Supply: Risks Every Distributor Should Understand
Quality & Compliance
- WHO-GMP Certification Explained: What It Guarantees and What It Doesn't
- WHO-GMP vs US FDA vs EU-GMP: Understanding Pharmaceutical Quality Tiers
- How Pharmaceutical Facility Audits Work: Inside a Supplier Qualification Visit
- Bioequivalence Studies: When Generic Buyers Should Insist on BE Data
- Stability Zones Explained: Why Zone IVb Data Matters for Tropical Markets
- Data Integrity in Pharma Manufacturing: The ALCOA+ Principles for Buyers
- Counterfeit Medicines: How Legitimate Supply Chains Protect Themselves
- Pharmacovigilance Obligations for Importers and Distributors
- Understanding Pharmacopoeial Standards: IP vs BP vs USP
- What a Site Master File Tells You About a Manufacturer
- Batch Record Review: What Happens Before a Batch Is Released
- Handling Quality Complaints and Batch Recalls Across Borders
- Nitrosamine Impurities: What Importers Need to Know
- GDP (Good Distribution Practice) for Pharmaceutical Wholesalers
Business Strategy
- Why Private Label Is the Highest-Margin Move for Pharma Distributors in Emerging Markets
- Building a Pharmaceutical Distribution Business: From First Container to Market Leader
- Product Portfolio Strategy: How Many SKUs Should a New Distributor Launch?
- Contract Manufacturing vs Third-Party Manufacturing: Choosing Your Model
- How to Price Generic Medicines in Competitive Emerging Markets
- Territory Exclusivity Agreements: What to Negotiate and What to Concede
- From Trader to Brand Owner: The Private Label Transition Playbook
- Pharmacy Chain Supply Contracts: Winning and Keeping Them
- The Economics of Pharmaceutical Franchising in Africa
- Diversifying into Nutraceuticals: A Growth Lane for Pharma Distributors
- Working Capital Management for Pharmaceutical Importers
- How Distributors Should Evaluate New Molecule Opportunities
- Building a Field Force: Medical Rep Economics in Emerging Markets
- Exit Value: What Makes a Pharmaceutical Distribution Business Acquirable
Logistics
- Cold Chain to Africa: How Temperature-Sensitive Medicines Actually Survive the Journey
- Sea vs Air Freight for Pharmaceuticals: A Decision Framework
- Pharmaceutical Packaging for Tropical Climates: Alu-Alu, Tropicalization and Beyond
- Port Clearance Strategies: Cutting Demurrage on Medical Consignments
- Marine Insurance for Pharmaceutical Cargo: What Policies Actually Cover
- Serialization and Track-and-Trace: Global Requirements by Market
- Last-Mile Distribution of Medicines in Low-Infrastructure Markets
- Managing Pharmaceutical Shelf Life Across a Long Supply Chain
- Consolidated Shipments: The Economics of Multi-Manufacturer Containers
- Temperature Data Loggers: Specifications, Calibration and Compliance
- Pharma Warehousing Standards: What Importers Should Build or Rent
- Airport-to-Cold-Store: Designing the Riskiest 24 Hours in Pharma Logistics
Tenders & Institutions
- Winning Government Pharmaceutical Tenders: The Technical Checklist That Decides Before Price Does
- How WHO Prequalification Shapes Global Tender Eligibility
- Supplying the Global Fund, UNICEF and PEPFAR Programs: Requirements Overview
- Bid Securities and Performance Guarantees in Pharma Tenders
- Hospital Formulary Supply: Structuring Multi-Year Contracts
- NGO Medicine Procurement: Standards, Kits and Donation Compliance
- National Essential Medicine Lists: How They Shape Procurement
- Framework Agreements vs Spot Tenders: Institutional Buying Models
- Post-Award Fulfilment: Why Delivery Performance Wins the Next Tender
- Interagency Emergency Health Kits: Composition and Supply Logistics
- Pooled Procurement Mechanisms in Africa: AMA, ZaZiBoNa and Beyond
- Anti-Corruption Compliance in Government Pharmaceutical Supply
Regulatory
- Product Registration in Africa: Building a Pipeline Instead of Chasing Approvals
- CTD Dossier Format Explained: The Five Modules and What Goes Wrong
- ACTD vs CTD: Dossier Requirements Across ASEAN and Beyond
- NAFDAC Registration Guide: Timelines, Requirements and Common Deficiencies
- Kenya PPB Registration: A Practical Walkthrough
- SFDA Registration for Saudi Arabia: What Gulf Compliance Requires
- Registering Medicines in Latin America: INVIMA, DIGEMID and COFEPRIS Compared
- Health Authority Deficiency Letters: Answering Them Fast and Final
- The African Medicines Agency: What Harmonization Means for Importers
- Free Sale Certificates, COPPs and Legalization: The Administrative Documents Explained
- Marketing Authorization Holdership: Why Distributors Should Own Their Registrations
- Variations and Renewals: Maintaining a Registration Portfolio
- Regulatory Requirements for Nutraceuticals vs Medicines by Market
- GMP Inspections by Foreign Authorities: Preparing a Site for Visiting Regulators
Industry Insights
- Why Indian Generics Power Global Health: The Numbers Behind the 'Pharmacy of the World'
- The African Pharmaceutical Market in 2026: Size, Growth and Local Manufacturing Policy
- API Supply Chains: How Active Ingredient Sourcing Shapes Generic Pricing
- Biosimilars in Emerging Markets: The Next Generic Wave
- Antimicrobial Resistance and the Responsible Antibiotics Supply Chain
- How Currency Volatility Shapes Pharmaceutical Import Strategy
- Local Manufacturing Mandates: Threat or Opportunity for Importers?
- The Rise of Gulf Pharmaceutical Markets: GCC Demand Trends
- Telepharmacy and Digital Health: Distribution Implications in Emerging Markets
- GLP-1 Agonists and Generic Timelines: What Distributors Should Prepare For
- Pharmaceutical Trends in Francophone West Africa
- Vaccine Manufacturing Capacity: The Post-Pandemic Global Map
- ESG in Pharmaceutical Supply Chains: What Buyers Now Ask
- The Economics of Essential Medicines: Why Access Pricing Works
- Halal Pharmaceuticals: Certification, Markets and Formulation
- Women's Health Portfolios: The Under-Served Opportunity in Emerging Markets
- Pediatric Formulation Innovation: Dispersibles, Taste-Masking and Dosing Accuracy
- Oncology Access Programs in Low- and Middle-Income Countries
- How AI Is Changing Pharmaceutical Demand Forecasting
- India's Pharma Vision 2030: Policy, PLI Schemes and Export Implications
Ready to discuss your market?
Send us your product list, tender specification or private-label brief. A senior export manager — not a chatbot — replies within one business day.
Or message our export desk on WhatsApp